Microbot Medical Valuation
| MBOT Stock | USD 1.52 0.04 2.56% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Microbot Medical secures a last-minute Real Value of $3.07 per share. The latest price of the firm is $1.52. Our model forecasts the value of Microbot Medical from analyzing the firm fundamentals such as Return On Equity of -2.01, shares owned by insiders of 1.62 %, and Current Valuation of 51 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Microbot Medical's valuation include:
Undervalued
Today
Please note that Microbot Medical's price fluctuation is extremely dangerous at this time. Calculation of the real value of Microbot Medical is based on 3 months time horizon. Increasing Microbot Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Microbot Medical's intrinsic value may or may not be the same as its current market price of 1.52, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.52 | Real 3.07 | Target 8.0 | Hype 1.56 | Naive 1.4 |
The intrinsic value of Microbot Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Microbot Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Microbot Medical helps investors to forecast how Microbot stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Microbot Medical more accurately as focusing exclusively on Microbot Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Microbot Medical's intrinsic value based on its ongoing forecasts of Microbot Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Microbot Medical's closest peers.
Microbot Medical Cash |
|
Microbot Valuation Trend
Microbot Medical's real value is important for investors to make better decisions and a more accurate overall view of Microbot Medical's financial worth over time. Using both Microbot Medical's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Microbot Medical Total Value Analysis
Microbot Medical is now estimated to have valuation of 51 M with market capitalization of 55.24 M, debt of 231 K, and cash on hands of 9.29 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Microbot Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
51 M | 55.24 M | 231 K | 9.29 M |
Microbot Medical Asset Utilization
One of the ways to look at asset utilization of Microbot is to check how much profit was generated for every dollar of assets it reports. Microbot Medical secures a negative usage of assets of -0.91 %, losing $0.009101 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Microbot Medical shows how discouraging it operates for each dollar spent on its assets.Microbot Medical Ownership Allocation
Microbot Medical maintains a total of 34.74 Million outstanding shares. Roughly 90.9 % of Microbot Medical outstanding shares are held by general public with 1.62 pct. owned by insiders and only 7.48 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Microbot Medical Profitability Analysis
Net Loss for the year was (10.74 M) with profit before overhead, payroll, taxes, and interest of 0.About Microbot Medical Valuation
The stock valuation mechanism determines Microbot Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Microbot Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Microbot Medical. We calculate exposure to Microbot Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Microbot Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -95.4 K | -90.6 K | |
| Pretax Profit Margin | (357.92) | (375.81) | |
| Operating Profit Margin | (360.92) | (342.88) | |
| Net Loss | (357.93) | (340.03) | |
| Gross Profit Margin | 0.77 | 0.73 |
Microbot Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Microbot Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.2 M |
Microbot Medical Current Valuation Indicators
Microbot Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Microbot Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Microbot Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Microbot Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Microbot Medical's worth.Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.